Skip to main content

A research digest of the CJC-1295 + ipamorelin stack: GHRH analogue plus selective GHRP, and what the literature actually measured.

masthead // what this is

About CJC-1295 Ipamorelin Compound

A synthesis of the two-peptide literature. Not a clinic, not a vendor.

What this site is

CJC-1295 Ipamorelin Compound is a synthesis of the peer-reviewed literature on the CJC-1295 + ipamorelin combination — the several strands of published research drawn together into one reading. No clinic runs it and no clinician staffs it; it gives no medical advice, makes no product, and sells nothing. It reads publicly available science and pulls it together, and that is all it does.

The "compound" in the name is editorial framing — a position this publisher occupies relative to the literature on a research compound, not a claim to be a compounding pharmacy or to offer any product or service. There is no checkout here and nothing to buy.

How we read the evidence

The method is plain: state the number, mark the source, leave the gaps visible. Where a finding was measured — CJC-1295's GH and IGF-1 elevations, ipamorelin's selectivity, the GHRP+GHRH synergy — we report it with a citation. Where the combination is inferred from single-component data and general synergy work using related peptides, we say so rather than implying the fixed blend was clinically proven.

We keep the two honesty constraints front and center on every page: neither component is FDA-approved, and the fixed CJC-1295 + ipamorelin combination has never been tested in a controlled clinical trial. The downstream effects people report are logged as anecdote, separated from the cited literature. No human dosing appears anywhere.

How we read the evidence

What we don't do

We don't sell peptides, recommend doses, or offer consultations. We don't name drug brands or compare against branded GH products. We don't invent people, addresses, or a clinical team — there are none. We don't claim the stack treats, cures, or prevents anything.

What we do is narrow and deliberate: read the published record on this research combination, render it in plain English alongside the technical detail, and cite all of it. The compounds described are research chemicals; this is a synthesis of what the science says about them.